Author/Creator: Ganzevles, S. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Ganzevles, S.

1. 33 Cetuximab paying toll to improve its therapeutic efficacy – Improving cetuximab-mediated head and neck cancer treatment via co-activation of Fc-receptors and toll-like receptors. Issue 5 (May 2015)

Authors:: Ganzevles, S.; Tuk, K.; van Egmond, M.; Leemans, C.R.; Braakhuis, B.J.M.; Brakenhoff, R.H.
Journal:: Oral oncology
Issue:: Volume 51:Issue 5(2015:May)
Page Start:: e37
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. 33 Cetuximab paying toll to improve its therapeutic efficacy – Improving cetuximab-mediated head and neck cancer treatment via co-activation of Fc-receptors and toll-like receptors. Issue 5 (May 2015)

Authors:: Bakema, J.; Ganzevles, S.; Tuk, K.; van Egmond, M.; Leemans, C.R.; Braakhuis, B.J.M.; Brakenhoff, R.H.
Journal:: Oral oncology
Issue:: Volume 51:Issue 5(2015:May)
Page Start:: e37
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. 33 Cetuximab paying toll to improve its therapeutic efficacy – Improving cetuximab-mediated head and neck cancer treatment via co-activation of Fc-receptors and toll-like receptors. Issue 5 (May 2015)

Authors:: Bakema, J.; Ganzevles, S.; Tuk, K.; van Egmond, M.; Leemans, C.R.; Braakhuis, B.J.M.; Brakenhoff, R.H.
Journal:: Oral oncology
Issue:: Volume 51:Issue 5(2015:May)
Page Start:: e37
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. O5.3 The tumor immune microenvironment of HPV-negative and HPV-positive oropharynx squamous cell carcinomas. (November 2022)

Authors:: Muijlwijk, T.; Nijenhuis, D.; Ganzevles, S.; Leemans, R.; Brakenhoff, R.; van de Ven, R.
Journal:: Oral oncology
Issue:: Volume 134(2022)Supplement
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗